A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
Pilatus Biosciences Inc
Pilatus Biosciences Inc
Revolution Medicines, Inc.
Celldex Therapeutics
National Cancer Institute (NCI)
Revolution Medicines, Inc.
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Poniard Pharmaceuticals
Poniard Pharmaceuticals
Pharmacyclics LLC.